Multiple pathways of disease and remedy defined
Research Highlights
Potential biomarker identified for SPG5
Spinal cord area measurements definitive
HSP misdiagnosed as CP in children
Advanced genetic testing vital
3 new HSP gene candidates
KPNA3, VRK1 and ABHD16A proposed
Brain imaging studies of AP-4 HSP group
Improving early diagnosis & prognosis
Ancient herbal remedy for neurological disorders
Potential for treating SPG20
New HSP genotypes and phenotypes
Research from South Korea, Finland, China, Spain, Turkey, Bahrain, Japan, Spain, Germany, Poland, Australia, Singapore, France, Taiwan, UK, Italy, India
Compound stops neuron degeneration
Potential relevance for HSP, PLS, MND
Brain damage ‘a conspicuous feature’ of HSP
Different damage patterns depending on type
Identifying common impaired cell functions in HSP
Future drug treatments for multiple types